SL Therapeutics, Inc.

XKON:A258540 Stock Report

Market Cap: ₩4.7b

SL Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A258540?
Owner TypeNumber of SharesOwnership Percentage
General Public250,5964.81%
VC/PE Firms427,6748.2%
Individual Insiders2,038,75939.1%
Private Companies2,496,94147.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 95.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30%
Smb Investment Co, Ltd..
1,564,975₩1.4b0%no data
15.1%
Jong Sung Choi
789,474₩718.4m0%no data
14.2%
Jong-Ha Yoon
742,128₩675.3m0%no data
12.5%
New Run Hybrid Investment Fund 2
648,921₩590.5m0%no data
8.2%
LB Investment Inc.
427,674₩389.2m0%1.09%
6.94%
Seung-Kwon You
362,000₩329.4m0%no data
5.43%
Hamisu Llc
283,045₩257.6m0%no data
2.78%
Donghoon Oh
145,157₩132.1m0%no data